FGF23 and osteomalacia: Although there have been no previous studies in which IHC with PIDs was applied to bone tissue, the quantification of the FGF23 expression level in the bone was expected to be substantiated with this method, thus enabling us to elucidate the pathophysiology of alcoholic osteomalacia.